Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Australia-based biotechnology company CSL has partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Queensland (UQ) to advance the university’s Covid-19 vaccine.
The aim is to speed up the development, manufacture and distribution of the vaccine. CEPI and CSL agreed to fund development and manufacturing activities.
Funding will support the pending Phase I safety clinical trial led by the university, followed by subsequent late-stage studies.